Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
Standard
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties? / Bielack, S S; Erttmann, Rudolf; Kempf-Bielack, B; Winkler, K.
In: EUR J CANCER, Vol. 32, No. 10, 10, 1996, p. 1652-1660.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?
AU - Bielack, S S
AU - Erttmann, Rudolf
AU - Kempf-Bielack, B
AU - Winkler, K
PY - 1996
Y1 - 1996
M3 - SCORING: Zeitschriftenaufsatz
VL - 32
SP - 1652
EP - 1660
JO - EUR J CANCER
JF - EUR J CANCER
SN - 0959-8049
IS - 10
M1 - 10
ER -